A1 Refereed original research article in a scientific journal
Eicosanoid Inflammatory Mediators Are Robustly Associated With Blood Pressure in the General Population
Authors: Palmu J, Watrous JD, Mercader K, Havulinna AS, Lagerborg KA, Salosensaari A, Inouye M, Larson MG, Rong J, Vasan RS, Lahti L, Andres A, Cheng SS, Jousilahti P, Salomaa V, Jain M, Niiranen TJ, Niiranen TJ
Publisher: WILEY
Publication year: 2020
Journal: Journal of the American Heart Association
Journal name in source: JOURNAL OF THE AMERICAN HEART ASSOCIATION
Journal acronym: J AM HEART ASSOC
Article number: ARTN e017598
Volume: 9
Issue: 19
Number of pages: 31
ISSN: 2047-9980
DOI: https://doi.org/10.1161/JAHA.120.017598
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/51211801
Background Epidemiological and animal studies have associated systemic inflammation with blood pressure (BP). However, the mechanistic factors linking inflammation and BP remain unknown. Fatty acid-derived eicosanoids serve as mediators of inflammation and have been suggested to regulate renal vascular tone, peripheral resistance, renin-angiotensin system, and endothelial function. We hypothesize that specific proinflammatory and anti-inflammatory eicosanoids are linked with BP. Methods and Results We studied a population sample of 8099 FINRISK 2002 participants randomly drawn from the Finnish population register (53% women; mean age, 48±13 years) and, for external validation, a sample of 2859 FHS (Framingham Heart Study) Offspring study participants (55% women; mean age, 66±9 years). Using nontargeted liquid chromatography-mass spectrometry, we profiled 545 distinct high-quality eicosanoids and related oxylipin mediators in plasma. Adjusting for conventional hypertension risk factors, we observed 187 (34%) metabolites that were significantly associated with systolic BP (P
Downloadable publication This is an electronic reprint of the original article. |  |
